Raman Singh
Direktor/Vorstandsmitglied bei LIQUIDIA CORPORATION
Vermögen: - $ am 30.04.2024
Aktive Positionen von Raman Singh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LIQUIDIA CORPORATION | Direktor/Vorstandsmitglied | 28.06.2020 | - |
Independent Dir/Board Member | 28.06.2020 | - | |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Direktor/Vorstandsmitglied | 01.12.2020 | - |
Independent Dir/Board Member | 01.12.2020 | - | |
Juniper Biologics Pte Ltd.
Juniper Biologics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Juniper Biologics Pte Ltd is a science-led pharmaceutical company based in Singapore, Singapore. Juniper Biologics is backed by the Sylvan Group and is focused on delivering novel therapies to improve the health and quality of life of patients. The Singaporean company has a growing presence in oncology and oncology supportive care, rare/orphan diseases, and gene therapy. The company was founded with a vision to provide treatments for unmet medical needs in specialist therapy areas. Raman Singh has been the CEO of the company since 2020. | Vorstandsvorsitzender | 01.12.2020 | - |
Karriereverlauf von Raman Singh
Ehemalige bekannte Positionen von Raman Singh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mundipharma Pte Ltd.
Mundipharma Pte Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma Pte Ltd. develops pharmaceutical products. Its therapy area includes analgesia, oncology, ophthalmology, respiratory, specialty care, and consumer healthcare. The company was founded in 2004 and is headquartered in Singapore. | Vorstandsvorsitzender | 01.10.2011 | 01.12.2020 |
GSK PLC | Corporate Officer/Principal | 01.01.2008 | 01.01.2011 |
Abbott Australia Pty Ltd. | Corporate Officer/Principal | 01.01.2007 | 01.01.2008 |
Abbott Laboratories NZ Ltd. | Corporate Officer/Principal | 01.01.2007 | 01.01.2008 |
Abbott Korea Ltd.
Abbott Korea Ltd. Medical DistributorsDistribution Services Abbott Korea Ltd. engages in the distribution of medical equipment, reagents, medicines, nutritional products, infant formula and baby foods. The company was founded on May 24, 1988 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | 01.01.2005 | 01.01.2007 |
Ausbildung von Raman Singh
Thunderbird School of Global Management | Graduate Degree |
Osmania University | Undergraduate Degree |
Assumption University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 4 |
Singapur | 3 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GSK PLC | Health Technology |
LIQUIDIA CORPORATION | Health Technology |
Private Unternehmen | 6 |
---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Abbott Korea Ltd.
Abbott Korea Ltd. Medical DistributorsDistribution Services Abbott Korea Ltd. engages in the distribution of medical equipment, reagents, medicines, nutritional products, infant formula and baby foods. The company was founded on May 24, 1988 and is headquartered in Seoul, South Korea. | Distribution Services |
Abbott Laboratories NZ Ltd. | |
Mundipharma Pte Ltd.
Mundipharma Pte Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma Pte Ltd. develops pharmaceutical products. Its therapy area includes analgesia, oncology, ophthalmology, respiratory, specialty care, and consumer healthcare. The company was founded in 2004 and is headquartered in Singapore. | Health Technology |
Abbott Australia Pty Ltd. | |
Juniper Biologics Pte Ltd.
Juniper Biologics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Juniper Biologics Pte Ltd is a science-led pharmaceutical company based in Singapore, Singapore. Juniper Biologics is backed by the Sylvan Group and is focused on delivering novel therapies to improve the health and quality of life of patients. The Singaporean company has a growing presence in oncology and oncology supportive care, rare/orphan diseases, and gene therapy. The company was founded with a vision to provide treatments for unmet medical needs in specialist therapy areas. Raman Singh has been the CEO of the company since 2020. | Commercial Services |
- Börse
- Insiders
- Raman Singh
- Erfahrung